scispace - formally typeset
R

Ramanan Laxminarayan

Researcher at Center for Disease Dynamics, Economics & Policy

Publications -  311
Citations -  33567

Ramanan Laxminarayan is an academic researcher from Center for Disease Dynamics, Economics & Policy. The author has contributed to research in topics: Antibiotic resistance & Population. The author has an hindex of 67, co-authored 287 publications receiving 25009 citations. Previous affiliations of Ramanan Laxminarayan include ETH Zurich & Resources For The Future.

Papers
More filters
Journal ArticleDOI

Economic burden of antibiotic resistance: how much do we really know?

TL;DR: The contributions and limitations of studies that estimates the disease burden attributable to antibiotic resistance and studies that estimate the economic burden of resistance are reviewed and discussed.
Posted ContentDOI

Epidemiology and transmission dynamics of COVID-19 in two Indian states

TL;DR: Comprehensive SARS-CoV-2 testing and contact-tracing data from the Indian states of Tamil Nadu and Andhra Pradesh reveal stark contrasts from epidemics affecting high-income countries, with 92% of cases and 59.7% of deaths occurring among individuals <65 years old.
Journal ArticleDOI

Clinical and Economic Outcomes Attributable to Health Care-Associated Sepsis and Pneumonia

TL;DR: Attributable hospital length of stay, hospital costs, and crude in-hospital mortality were estimated from discharge records using a multivariate matching analysis and a supplementary regression analysis.

Intervention Cost-Effectiveness: Overview of Main Messages

TL;DR: This chapter provides broad conclusions on the economic efficiency of using these interventions to improve health, and the resulting avertable burden of disease, for 319 interventions covering nearly every disease condition considered in the volume.
Journal ArticleDOI

Global geographic trends in antimicrobial resistance: the role of international travel.

TL;DR: The role of travel in the international dissemination of antimicrobial resistance is reviewed and actions at the levels of travelers, travel medicine practitioners, and policymakers that would mitigate this threat are considered.